6-L-dihydroxyethyl-2,4,7-trioxo-8-D-ribityl pteridine and process for producing the same
AssigneeNippon Zoki Pharmaceutical Co., Ltd.
InventorsMasuichi Takino, Teikichi Kurosaki, Munehiko Odaka
Life of this patent
Estimating the term…
Loading patent…
AssigneeNippon Zoki Pharmaceutical Co., Ltd.
InventorsMasuichi Takino, Teikichi Kurosaki, Munehiko Odaka
Estimating the term…
Trioxopteridine derivatives of the formula ##SPC1## , wherein R.sub.1 is a normal alkyl group having 0 to 6 hydroxyl groups and R.sub.2 is hydrogen or a normal lower alkyl group having 0 to 5 hydroxyl groups, are prepared by catalytically hydrogenating a 6-substituted-5-nitro-2,4-dioxopyrimidine to give a 6-substituted-5-amino-2,4-dioxopyrimidine, and then reacting the latter compound with a compound of the formula R.sub.2 --A--COOR.sub.3, wherein R.sub.3 is hydrogen, lower alkyl, an alkali metal or an alkaline earth metal and A is carbonyl or a group of the formula ##EQU1## wherein R.sub.4 is lower alkyl. The resulting trioxopteridine derivatives have analgesic and antiphlogistic properties and are therefore useful as pharmaceutical medicaments.
The compound 6-L-dihydroxyethyl-2,4,7-trioxo-8-D-ribityl pteridine.
Dependencies are inferred from the claim text.